Stock futures are flat after Dow reverses course to start busy earnings week

A trader works on the floor of the New York Stock Exchange (NYSE) in New York City, July 13, 2022. Brendan McDermid | Reuters Stock futures were flat after the Dow Jones Industrial Average slumped mor...

9 Dividend Aristocrat Stocks That Could Ride Out a Recession

Although Hormel shares are down this year, the company is among nine Dividend Aristocrats that figure to show some resilience if a recession comes to pass. Michael Edwards/Dreamstime.com Text size Wit...

Jim Cramer picks 4 ‘buyable’ stocks to snap up after ugly market days

CNBC’s Jim Cramer recommended four stocks investors should consider adding to portfolios after ugly days in the market like Tuesday. “While this may be a bear market, as long as commodity ...

FDA panel recommends changing Covid shots to fight omicron this fall

A healthcare worker prepares a syringe with the Moderna COVID-19 vaccine at a pop-up vaccination site operated by SOMOS Community Care during the COVID-19 pandemic in Manhattan in New York City, Janua...

The Days of Big Pharma Are Over. Big Biotech Is on Its Way.

W hen GlaxoSmithKline spins off its enormous division selling drugstore staples like Advil and Tums next month, it will represent more than just the latest shuffling of assets among corporate giants. ...

Is Johnson & Johnson A Recession-Proof Stock?

AFP via Getty Images Key Takeaways There is increased talk of a potential recession in the cards over the next 12 months Periods of negative economic growth can create a challenging environment for so...

FDA decision on Novavax’s Covid shots could be delayed

A health worker prepares a dose of the Novavax vaccine as the Dutch Health Service Organization starts with the Novavax vaccination program on March 21, 2022 in The Hague, Netherlands. Patrick Van Kat...

Novavax vaccine clears key step on path to FDA authorization

Novavax’s two-dose Covid-19 vaccine for adults ages 18 and older cleared a key step on the path toward Food and Drug Administration authorization on Tuesday. The FDA’s committee of indepen...

Novavax faces high-stakes FDA review this week that will decide the fate of its Covid vaccine in the U.S.

In this photo illustration the Food and Drug Administration (FDA) and Novavax logos are seen behind a medical syringe and vials. Pavlo Gonchar | LightRocket | Getty Images Novavax’s Covid-19 vac...

Here Are 6 Stocks That Pay a Lot in Dividends and Have Solid Yields. And Microsoft and Apple.

PepsiCo total quarterly dividend payout and yield make for an intriguing combination. Here, a Pepsi display at a shop in Grovetown, Ga., earlier this year. Billy Blume/Dreamstime.com Text size Sometim...

Covid-Hit Shanghai To Allow Gradual Reopening Of Malls And Markets, Xinhua Says

Members of a disinfection crew ride bicycles down a street in Shanghai, China on Saturday, May 7. … [+] Source: Bloomberg © 2022 Bloomberg Finance LP Shanghai will gradually allow shopping malls...

Novavax confident Covid vaccine will receive FDA authorization in June after delays

Novavax is confident its Covid-19 vaccine will receive the endorsement of the Food and Drug Administration’s advisory committee early this summer, executives said this week. The FDA committee is...

J&J names Thibaut Mongon as CEO of spin-off consumer health company

Signage is displayed outside of Johnson & Johnson headquarters in New Brunswick, New Jersey, Aug. 1, 2020. Mark Kauzlarich | Bloomberg | Getty Images Johnson & Johnson on Wednesday announced t...

Under Armour, Cigna, DraftKings and others

Check out the companies making headlines before the bell: Under Armour (UAA) – The athletic apparel maker posted an adjusted first-quarter loss of 1 cent per share, compared with a profit estimate of ...

Cramer’s lightning round: Stay away from CoreCivic

Loading chart… CoreCivic Inc: “Let’s just stay away.” Loading chart… Inmode Ltd: “If you want med tech, you just want Edwards Lifesciences.” Loading chartR...

FDA Limits Use Of Johnson & Johnson Vaccine Due To Blood Clot Risk

Topline Johnson & Johnson’s coronavirus vaccine is now only authorized for U.S. adults who are unable to receive other vaccines, the Food and Drug Administration announced Thursday, citing the Joh...

Johnson & Johnson, Schlumberger Boosted Dividends

Johnson & Johnson, Southern Co., and Schlumberger were among the large U.S. companies that declared dividend this week. Healthcare conglomerate Johnson & Johnson (ticker:JNJ) plans to boost it...

12 U.S. manufacturers investors should keep an eye on

CNBC’s Jim Cramer on Thursday named 12 American manufacturers investors should keep an eye on to take advantage of what he calls the country’s “industrial renaissance.” “...

Jim Cramer names 4 stocks that can endure Fed tightening

CNBC’s Jim Cramer on Wednesday named four stocks that he believes can keep investors steady through market turmoil. “As someone who thinks it’s a good idea to stay in the market, I&#...

Twitter, Johnson & Johnson, WeWork and more

Vials labelled “COVID-19 Coronavirus Vaccine” and syringe are seen in front of displayed Johnson & Johnson logo in this illustration taken, February 9, 2021. Dado Ruvic | Reuters Check...

Netgear, Zendesk, WeWork and more

Take a look at some of the biggest movers in the premarket: Netgear (NTGR) – Netgear tumbled 10.6% in premarket trading after the networking equipment maker reported weaker-than-expected preliminary r...

Covid and JNJ earnings Q1 2022

Syringes and a box of Johnson & Johnson vaccine. Paul Hennessy | SOPA Images | LightRocket | Getty Images Johnson & Johnson on Tuesday lowered its full-year sales and earnings outlook, and sto...

Watch bonds & Ukraine as earnings season picks up

CNBC’s Jim Cramer on Thursday previewed next week’s slate of earnings and what investors should have on their radar to prepare for the tumultuous market ahead. The “Mad Money” ...

U.S. State Department Orders Non-Emergency Staff In Shanghai To Leave Amid Covid Surge

Volunteers transport boxes of food delivered by the government in Shanghai amid Covid lockdowns on … [+] Saturday, April 9.. Photographer: Qilai Shen/Bloomberg © 2022 Bloomberg Finance LP The U....

Pfizer’s New CFO David Denton Negotiated One of the Biggest Healthcare Deals in History

Pfizer on Monday named a new chief financial officer with a resume that hints at the company’s plans to spend big with its Covid-19 vaccine windfall. David Denton is taking up the CFO role at Pfizer (...

Value Investing Is Back. But How Do You Choose the Right ETF?

Value investing is coming back. Over the past decade, growth stocks have outpaced value shares, which usually have lots of tangible assets relative to their market value. In those 10 years, the S&...

Next decade will transform health care more than past century: J&J CEO

Andrew Harrer | Bloomberg | Getty Images Joaquin Duato, the new CEO of Johnson & Johnson, is comfortable enough in his new position at the 135-year-old company to issue a bold claim just a few mon...

Pfizer, Moderna and J&J Face Shareholder Pressure to Broaden Covid-19 Vaccine Access

Socially conscious investors and global-health activists are turning to shareholders to press Covid-19 vaccine manufacturers Pfizer Inc., Moderna Inc. and Johnson & Johnson to make more of their s...

Warren Buffett Puts Some of His $144 Billion to Work With Alleghany Deal

Warren Buffett Paul Morigi/Getty Images for Fortune/Time Inc Text size It was only three weeks ago that Berkshire Hathaway Chairman and CEO Warren Buffett wrote of the unpleasantness associated with h...

Vaccine maker stocks rise as China battles worst Covid outbreak since 2020

Health workers dressed in protective clothing give nucleic acid tests to men at a mass testing site to prevent COVID-19 on March 14, 2022 in Beijing, China. Kevin Frayer | Getty Images Shares of the m...

Pfizer planning to submit data on 4th Covid shot soon, while working on vaccine for all variants

Pfizer plans to submit data to the Food and Drug Administration for a fourth Covid shot soon, and it’s working on a vaccine that protects against all coronavirus variants, CEO Albert Bourla told...

Risk Of Covid Hospitalization 5 Times Higher With Johnson & Johnson Shot Than Pfizer

Topline Johnson & Johnson’s Covid-19 vaccine was far less effective at keeping people out of hospital than the Pfizer-BioNTech shot, according to a peer reviewed study published in JAMA Network Op...